As a leader in spine technology innovation, we continue to focus on transforming spine surgery to deliver clinically-proven surgical outcomes. Learn more about the NuVasive Spine Lineup featuring: X360™, Advanced Materials Science™ & Paediatrics.
NuVasive U.K. was founded in 2008 with the introduction of the XLIF platform and surgeon driven interoperative neuromonitoring. Our goals are to become the most trusted partner to our patients and customers, and to transform outcomes through best in class surgical technologies.
Through Advanced Materials Science, NuVasive strives to develop proprietary surface and structural technologies to enhance the osseointegration and biomechanical properties of surgical materials. The breakthrough technologies designed through Advanced Materials Science are rooted in three key principles:
Surface
Developing technologies that enhance osseointegration while increasing stability and resistance to expulsion.
Structure
Engineering material structures to mimic the elastic modulus of bone while maintaining durability.
Imaging
Designing technologies that improve visualization on a variety of imaging modalities.
NuVasive are able to address the challenges of Early Onset Scoliosis (EOS) with surgical technologies that address these conditions.
MAGEC - The Magec System offers a unique treatment for early onset Scoliosis by providing a less invasve solution to manage growth and progression of spinal defmority in growing children. The System consists of an adjustable growing rod and a external remote controller (ERC) that features magnetic technology allowing for noninvasive control of the implanted device. As a result, MAGEC helps reduce associated complication risks from repetitive surgeries, and simplifies the care and journey of an EOS patient.
RELINE SMALL STATURE - NuVasive® now offers the first low-profile fixation solution
for pediatrics that accepts 4.5, 4.75, 5.0mm rods and the new MAGEC® 5.0mm rod. Reline® Small Stature is a comprehensive pediatric deformity fixation system designed to address implant-related complications with solutions that increase overall construct strength with a reduced implant profile.
Telephone: 0044 (0)208 238 7850
Email: [email protected]
In order to ensure such compliance, NuVasive has adopted a comprehensive compliance program, entitled NuVasive Global Business Ethics and Compliance Program, which is designed to prevent, detect, and deter unethical business conduct, or violations of law or Company policy.
The NuVasive Integrity Hotline can be reached in the U.K. at 0-800-591-9068